April 3, 2017 / 11:30 AM / 4 months ago

BRIEF-Matinas Biopharma on track to report interim phase 2 data of MAT2203 in June 2017

1 Min Read

April 3 (Reuters) - Matinas Biopharma Holdings Inc:

* Matinas Biopharma reports 2016 financial results and provides corporate update

* Matinas Biopharma Holdings Inc - on track to report interim phase 2 data of MAT2203 and topline data of MAT2203 VVC study in June 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below